We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 27, 2026, in Amendment No. 2 to the Registration Statement (Form S-4 No. 333-299079) and related proxy statement/prospectus of Werewolf Therapeutics, Inc. dated November 10, 2026.

/s/ Ernst & Young LLP

Boston, Massachusetts

November 10, 2026

---